Video visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Cancer and Hematology Center
Brain Tumor Program
Solid Tumor Programs
Bone Tumor Program
Ewing Sarcoma Center
Liver Tumor Program
Rare Tumors Program
Soft Tissue Sarcoma Program
Texas Medical Center
6621 Fannin St., Ste. 1510.15
Houston, TX 77030
Murali M. Chintagumpala, MD
Clinical Director, Brain Tumor Program
Co-Director, Retinoblastoma Program
Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
|Baylor College of Medicine||Fellowship||Hematology/Oncology||1992|
|Columbus Hospital Program||Residency||Pediatrics||1988|
|University Teaching Hospital||Residency||Jr. Resident Medical Officer||1984|
|Government General Hospital||Internship||Rotating Internship||1983|
|Madras Medical College||Medical School||Doctor of Medicine||1981|
Dr. Murali Chintagumpala is Clinical Director of the Brain Tumor Program and Co-Director of the Retinoblastoma Program. He oversees all clinical and clinical research activities involving children with brain tumors and solid tumors at Texas Children's Cancer and Hematology Center. His specific interests include the management of children with all brain tumors, retinoblastoma, bone tumors, and kidney tumors.
His extensive background in treating children with brain tumors has led him to become the Principal Investigator representing Baylor College of Medicine in the Pediatric Brain Tumor Consortium. He serves as member of the Brain Tumor Committee within the Children’s Oncology Group (COG) and serves an active role at Texas Children's Cancer Center where he is Co-Director of our Brain Tumor Program.
In addition, Dr. Chintagumpala is a Clinical Co-Director of the Retinoblastoma Center of Houston. At the national level, he serves as chair of the Retinoblastoma Committee within the Children’s Oncology Group and is a leader in conducting clinical trials involving children with retinoblastoma.
As Director of our Solid Tumor Programs, he is an experienced clinician expert in the management of children with bone tumors, liver tumors and kidney tumors. He is the principal investigator of a multi-institutional study designed to improve survival in patients with osteosarcoma as part of the Bone Tumor Program.
Dr. Chintagumpala is a graduate of Madras Medical College in India. He then completed his residency at Columbus Hospital in Chicago, Illinois, then attended Baylor College of Medicine where he graduated from the Fellowship Program in Pediatric Hematology/Oncology. He is board certified in pediatric Hematology/Oncology by the American Board of Pediatrics.
|American Society of Clinical Oncology (ASCO)||Member|
|American Society of Pediatric Hematology and Oncology (ASPHO)||Member|
|Children's Oncology Group (COG)||Member|
|Children's Oncology Group (COG), Brain Tumor Committee||Member|
|Children's Oncology Group (COG), Renal Tumors Committee||Member|
|Children's Oncology Group (COG), Retinoblastoma Committee||Chair|
|Pediatric Brain Tumor Consortium (PBTC)||Member|
Q&A: Brain Tumor Program | Texas Children's Cancer Center
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.